Trusted Sources

ESTRACE Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

ESTRACE Safety Reports

Total ESTRACE reports: 145. ESTRACE FDA safety alerts: No. Reported deaths: 4    Reported hospitalizations: 5. Read More Here.

< Previous  Showing 101-145 of 145

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 17, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: influenza like illness. ESTRACE dosage: unknown. Patient recovered.

ESTRACE problem was reported by a Health Professional from UNITED STATES on Apr 25, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: dry mouth, lethargy, performance status decreased, thinking abnormal. ESTRACE dosage: FORM = 1-2 MG A DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on May 03, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: dysarthria, dyskinesia, dysphonia, fatigue. ESTRACE dosage: unknown. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on May 18, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast tenderness, pain. ESTRACE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on May 30, 2006. Female patient, 39 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: weight increased. ESTRACE dosage: unknown. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 10, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast cancer female. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, MEDROXYPROGESTERONE ACETATE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 11, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: ovarian cancer. ESTRACE dosage: unknown. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, MEDROXYPROGESTERONE, CYCRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 11, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROGESTERONE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 12, 2006. Female patient, 60 years of age, weighting 127.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: pancreatitis. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, THYROID. Patient was hospitalized. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, MEDROXYPROGESTERONE ACETATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 13, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, PROVERA, CYCRIN, MEDROXYPROGESTERONE ACETATE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, MEDROXYPROGESTERONE ACETATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 18, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, PREMPRO, PROVERA, MEDROXYPROGESTERONE ACETATE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRATEST, CYCRIN, ORTHO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 18, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMPRO, PROVERA, MEDROXYPROGESTERONE ACETATE. Patient recovered.

ESTRACE problem was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, 57 years of age, weighting 89.90 lb, was diagnosed with breast cancer and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, breast pain, herpes zoster, infection, white blood cell count increased. ESTRACE dosage: 10 MG TID PO. During the same period patient was treated with ACETAMINOPHEN, NEXIUM, NEURONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Jan 23, 2006. Female patient, 68 years of age, weighting 105.8 lb, was diagnosed with menopause and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRATAB, PREMARIN, PROVERA. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2005. Female patient, 69 years of age, weighting 138.9 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: pruritus, rash, skin discolouration, skin haemorrhage, skin nodule. ESTRACE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Feb 02, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: anxiety, nervousness. ESTRACE dosage: unknown. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: muscle spasms. ESTRACE dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 63 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, ORTHO, PREMPRO. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 46 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 68 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: ovarian cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 69 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, PROVERA, MEDROXYPROGESTERONE, CYCRIN. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 55 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 62 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, FEMHRT, PREMPRO. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 62 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer metastatic. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, PREMPRO. Patient died on 02/16/2006.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 31, 2006. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN. Patient died on 04/30/2005.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, ESTRADIOL, PROMETRIUM, MEDROXYPROGESTERONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 07, 2006. Female patient, 52 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, ESTRATEST, VAGIFEM. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2006. Female patient, 55 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMPRO, PREMARIN, MEDROXYPROGESTERONE, FEMHRT, PROVERA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on May 01, 2006. Female patient, 70 years of age, weighting 191.8 lb, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, breast cancer female. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, CYCRIN, MEDROXYPROGESTERONE ACETATE, PREMPRO. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, AYGESTIN, EVISTA. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 07, 2006. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: ovarian cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PREMARIN, PROVERA, MEDROXYPROGESTERONE. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 28, 2006. Female patient, 74 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROMETRIUM. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 53 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, PREMARIN, ESTRATEST, CLIMARA, PROGESTERONE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 28, 2006. Female patient, 50 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN. Patient recovered.

ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRACE CREAM, PREMARIN, PREMPRO, ESTRATEST, CENESTIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Sept 05, 2006. Female patient, 64 years of age, weighting 134.9 lb, was diagnosed with vulvovaginal dryness and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: altered visual depth perception, headache, optic neuritis, vaginal infection, vision blurred. ESTRACE dosage: 1 MG TWICE A WEEK, VAGINAL. Patient recovered.

< Previous  Showing 101-145 of 145